Kore Private Wealth’s Novartis NVS Stock Holding History

Kore Private Wealth’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,114	Closed	-$336K	–	416
2021 Q3	$336K	Buy	4,114 +1,084	+36%	+$97.5K	0.04%	307
2021 Q2	$276K	Buy	3,030 +367	+14%	+$32.7K	0.03%	333
2021 Q1	$228K	Buy	+2,663	New	+$239K	0.03%	322
2020 Q3	–	Sell	-809	Closed	-$70K	–	824
2020 Q2	$70K	Buy	809 +179	+28%	+$15.5K	0.01%	394
2020 Q1	$52K	Buy	630 +367	+140%	+$32.7K	0.01%	408
2019 Q4	$25K	Buy	+263	New	+$23.6K	﹤0.01%	593
2019 Q2	–	Sell	-212	Closed	-$18K	–	610
2019 Q1	$18K	Hold	212	–	–	﹤0.01%	521
2018 Q4	$16K	Buy	+212	New	+$16.5K	﹤0.01%	511

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Kore Private Wealth's NVS Position: Q4 2021 in Review

Kore Private Wealth sold out of Novartis (NVS) in Q4 2021, closing a stake of 4,114 shares — an estimated $336K sold.

Kore Private Wealth first reported a position in NVS in Q4 2018 and held it in 8 quarters. The position peaked at $336K in Q3 2021. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

Kore Private Wealth reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
Kore Private Wealth sold 4,114 Novartis shares in Q4 2021, an estimated $336K.
Kore Private Wealth first reported a position in Novartis in Q4 2018 and held it in 8 quarters.
Kore Private Wealth's Novartis position peaked at $336K in Q3 2021.
1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Kore Private Wealth's 13F filing for Q4 2021, filed 11 Feb 2022.